Management of familial hypercholesterolemias in adult patients: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
about
Challenges in the Diagnosis and Treatment of Homozygous Familial HypercholesterolemiaFamilial hypercholesterolemia: an under-recognized but significant concern in cardiology practicePregnancy after myocardial infarction and coronary artery bypass grafting - is it safe?Teratogenic risk of statins in pregnancy.Maternal Phytosterol Supplementation during Pregnancy and Lactation Modulates Lipid and Lipoprotein Response in Offspring of apoE-Deficient MiceCurrent view: indications for extracorporeal lipid apheresis treatment.The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia - a post-hoc analysis of a Phase 3, single-arm, open-label trial.Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment.How Do PCSK9 Inhibitors Stack Up to Statins for Low-Density Lipoprotein Cholesterol Control?Pregnancy after acute coronary syndrome: a proposal for patients' management and a literature review.Prospective multicentre study of the effect of voluntary plasmapheresis on plasma cholesterol levels in donors.PoLA/CFPiP/PCS Guidelines for the Management of Dyslipidaemias for Family Physicians 2016.Mipomersen (kynamro): a novel antisense oligonucleotide inhibitor for the management of homozygous familial hypercholesterolemia.LDL apheresis and inflammation--implications for atherosclerosis.Dyslipidemia: management using optimal lipid-lowering therapy.Lomitapide: a review of its use in adults with homozygous familial hypercholesterolemia.The need for combination drug therapies in patients with complex dyslipidemia.Novel treatments for familial hypercholesterolemia: pharmacogenetics at work.The role of antisense oligonucleotide therapy in patients with familial hypercholesterolemia: risks, benefits, and management recommendations.Recommendations for the management of patients with familial hypercholesterolemia.Lipoprotein apheresis in the management of familial hypercholesterolaemia: historical perspective and recent advances.Influence of maternal hypercholesterolemia and phytosterol intervention during gestation and lactation on dyslipidemia and hepatic lipid metabolism in offspring of Syrian golden hamsters.Survival in homozygous familial hypercholesterolaemia is determined by the on-treatment level of serum cholesterol.Familial hypercholesterolaemia.A systems analysis of age-related changes in some cardiac aging traits.POR*28 SNP is associated with lipid response to atorvastatin in children and adolescents with familial hypercholesterolemia.Familial hypercholesterolemia.
P2860
Q26787050-97F2628A-3BD5-48AD-8EF5-45768A3116DFQ26828401-AFF6F360-3057-483B-86CC-DF06F20991D3Q33555488-1FFA6E8D-4F00-4371-960B-727DB79D3F2AQ34643449-2F558799-9619-4C05-B885-07BC54759FDBQ35894304-A281D5DA-BFDD-4506-A25E-669ADCA61507Q36028650-A05F5884-66C2-43A3-8325-3D24E34EF398Q36069577-7BFB152F-F804-462D-9E00-2C2245513621Q36076131-F666F01B-392A-41A8-998C-E366484A1422Q36385726-DC829AD3-A0E1-44C0-990F-CC6F88E10BF1Q36948486-FBC8D286-ADE5-4E93-8A47-DD72D42FFC40Q37270109-4402C4C1-3F96-4282-A1F7-7B5F51A0B246Q37549374-B3E6E058-F074-4425-A532-E2E852F3E3F3Q37641306-E47ACE93-AD22-4F22-9DA1-514EEF259E05Q38016475-6BA9D69E-89E8-4A89-9911-457D68239407Q38049066-7BF38602-2AF5-4268-A708-A993D15B1529Q38110487-726A118C-402C-41D5-A9DD-5B7BEE042008Q38118163-6CC917EC-1561-4418-823E-851DB5305A86Q38217797-13EA2803-FAF6-4273-A4A7-A8211724AB6CQ38268342-150AC227-0DCB-4AA6-B5DF-234E6E6F3B0EQ38268915-A422234A-5EDF-4472-80F8-564778E14AA3Q38269605-9FED0344-003A-49B8-9BA6-61A6BF059A33Q41653870-F2869E3D-92A7-49AC-901F-EF9BF052831CQ46816057-F16797B4-9E50-4B4F-B5FC-36E82A7FBE6BQ47316095-7806DE1A-3F09-43FA-BB0B-BA3014A918FFQ50702939-99008BFC-20FC-4A6C-8706-3DE4B07A1059Q53665083-C88B6039-DC83-4AE8-AC38-C5785ED449DEQ55284678-E524195A-058F-45F0-B337-9700C6286B0B
P2860
Management of familial hypercholesterolemias in adult patients: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Management of familial hyperch ...... Familial Hypercholesterolemia.
@ast
Management of familial hyperch ...... Familial Hypercholesterolemia.
@en
Management of familial hyperch ...... Familial Hypercholesterolemia.
@nl
type
label
Management of familial hyperch ...... Familial Hypercholesterolemia.
@ast
Management of familial hyperch ...... Familial Hypercholesterolemia.
@en
Management of familial hyperch ...... Familial Hypercholesterolemia.
@nl
prefLabel
Management of familial hyperch ...... Familial Hypercholesterolemia.
@ast
Management of familial hyperch ...... Familial Hypercholesterolemia.
@en
Management of familial hyperch ...... Familial Hypercholesterolemia.
@nl
P2093
P1476
Management of familial hyperch ...... Familial Hypercholesterolemia.
@en
P2093
Mary P McGowan
Matthew K Ito
National Lipid Association Expert Panel on Familial Hypercholesterolemia
Patrick M Moriarty
P304
P356
10.1016/J.JACL.2011.04.001
P407
P433
P577
2011-04-08T00:00:00Z